SOMERSET, N.J.,, Jan. 25, 2018 -- MTBC (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider of proprietary, cloud-based healthcare IT solutions and services, will release its financial results for the three months and year ended December 31, 2017 before the market opens on Wednesday, March 7, 2018. The Company will follow with a conference call for investors on March 7 at 8:30 a.m. ET, during which management will review certain highlights of the fourth-quarter and full-year 2017, including:
- Achievement of full-year revenue and adjusted EBITDA guidance;
- 30% year-over-year revenue growth for full-year 2017;
- Highest quarterly and full-year adjusted EBITDA in MTBC’s history;
- Payoff of virtually all corporate debt during 2017; and
- Closing 2017 positioned for additional growth with an untapped $5 million credit facility and more than $4 million in cash.
The live webcast of the conference call can be accessed at ir.mtbc.com or by dialing 412-317-5131 and referencing “MTBC Fourth Quarter 2017 Earnings Call.” A replay of the conference call will be available approximately one hour after conclusion of the call at the same link, and will be accessible through June 30, 2018. The replay can also be accessed by dialing 412-317-0088 and providing access code 10116612.
Please visit MTBC’s Investor Relations website at ir.mtbc.com to view the MTBC Fact Sheet, Corporate Presentation, and listen to interviews with the MTBC leadership team.
About MTBC
Medical Transcription Billing, Corp. (MTBC) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC's common stock trades on the NASDAQ Capital Market under the ticker symbol “MTBC,” and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol “MTBCP.”
For additional information, please visit our website at www.mtbc.com.
Follow MTBC on TWITTER, LINKEDIN and FACEBOOK.
SOURCE MTBC Company and Investor Contact: Bill Korn Chief Financial Officer Medical Transcription Billing, Corp. [email protected] (732) 873-5133


Anta Sports Expands Global Footprint With Strategic Puma Stake
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Amazon Explores AI Content Marketplace With Media Publishers
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 



